Name | Number of supported studies | Average coverage | |
---|---|---|---|
microglial cell | 3 studies | 26% ± 1% | |
fibroblast | 3 studies | 21% ± 3% | |
macrophage | 3 studies | 24% ± 6% |
Insufficient scRNA-seq data for expression of CASS4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1655.67 | 578 / 578 | 79% | 3.26 | 912 / 1155 |
brain | 87% | 83.57 | 2294 / 2642 | 80% | 2.14 | 567 / 705 |
ovary | 96% | 179.96 | 173 / 180 | 59% | 1.32 | 255 / 430 |
breast | 92% | 85.50 | 420 / 459 | 54% | 1.21 | 607 / 1118 |
kidney | 71% | 65.33 | 63 / 89 | 66% | 2.34 | 594 / 901 |
intestine | 95% | 104.63 | 918 / 966 | 37% | 0.79 | 194 / 527 |
stomach | 75% | 51.73 | 270 / 359 | 53% | 1.22 | 152 / 286 |
liver | 94% | 84.35 | 213 / 226 | 28% | 0.50 | 112 / 406 |
prostate | 90% | 78.53 | 221 / 245 | 31% | 0.50 | 154 / 502 |
esophagus | 85% | 101.94 | 1234 / 1445 | 34% | 0.66 | 62 / 183 |
skin | 73% | 56.23 | 1324 / 1809 | 40% | 1.07 | 187 / 472 |
adrenal gland | 92% | 96.88 | 238 / 258 | 12% | 0.22 | 27 / 230 |
spleen | 100% | 536.81 | 241 / 241 | 0% | 0 | 0 / 0 |
bladder | 62% | 50.05 | 13 / 21 | 37% | 0.88 | 187 / 504 |
thymus | 64% | 44.24 | 419 / 653 | 34% | 0.67 | 203 / 605 |
uterus | 71% | 44.26 | 120 / 170 | 25% | 0.63 | 116 / 459 |
adipose | 96% | 143.22 | 1154 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 43% | 23.47 | 141 / 328 | 52% | 1.23 | 92 / 178 |
peripheral blood | 91% | 587.18 | 841 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 86% | 93.20 | 1143 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 72% | 2.89 | 21 / 29 |
heart | 58% | 37.05 | 503 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 51% | 1.15 | 23 / 45 |
muscle | 26% | 12.78 | 210 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1900026 | Biological process | positive regulation of substrate adhesion-dependent cell spreading |
GO_0061098 | Biological process | positive regulation of protein tyrosine kinase activity |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0007155 | Biological process | cell adhesion |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0016477 | Biological process | cell migration |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005925 | Cellular component | focal adhesion |
GO_1990782 | Molecular function | protein tyrosine kinase binding |
Gene name | CASS4 |
Protein name | Cas scaffold protein family member 4 (cDNA FLJ53493, highly similar to HEF-like protein) Cas scaffolding protein family member 4 (HEF-like protein) (HEF1-EFS-p130Cas-like protein) (HEPL) |
Synonyms | HEFL C20orf32 |
Description | FUNCTION: Docking protein that plays a role in tyrosine kinase-based signaling related to cell adhesion and cell spreading. Regulates PTK2/FAK1 activity, focal adhesion integrity, and cell spreading. . |
Accessions | ENST00000434344.2 [Q9NQ75-3] ENST00000360314.7 [Q9NQ75-1] ENST00000679887.1 [Q9NQ75-1] Q9NQ75 B4DII4 ENST00000679529.1 |